Document is current

Article History

Received: 23 December 2024

Accepted: 20 May 2025

First Online: 28 May 2025

Declarations

:

: S.S.D., D.S.A., A.Ø.K., S.M., and T.L.J. declare no competing financial or non-financial interests. T.J.K. declare consulting fees from BMS; payments or honoraria for lectures, presentations, speakers bureaus, manuskript writing or educational events from GSK, Astra Zeneca, and Amgen; support for attending meetings and/or travel from MSD, Astra Zeneca, and GSK; participation on Data Safety Monitoring Board or Advisory Board for Astra Zeneca, MSD, and Abbvie. G.B.N declare support for attending meetings and/or travel from GSK. J.H. declare consulting fees from Pharmathen SA; unpaid role as Chair of the Steering Committee MASCC/ESMO and a member of the group responsible for developing the Antiemetic Guideline Update 2023. C.H.R. declare institutional funding (unrestricted grant) from Helsinn Healthcare for the work reported in this manuscript; member of the Steering Committee for the MASCC/ESMO Antiemetic Guideline Update 2023; consultant fee from Astellas Pharma; honoraria for lectures from Bristol Myers Squibb, Helsinn Healthcare, Pharmanovia; institutional funding for a clinical trial from the Novo Nordisk Foundation.